CURATIVE BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 USD | -66.67% |
|
0.00% | -66.67% |
| Current month | -66.67% | ||
| 1 month | -66.67% |
Financials (USD)
| Sales 2016 | - | Sales 2017 | - | Capitalization | 1.77M |
|---|---|---|---|---|---|
| Net income 2016 | -1M | Net income 2017 | - | EV / Sales 2016 | - |
| Net Debt 2016 | 50.03K | Net Debt 2017 | 62.83K | EV / Sales 2017 | - |
| P/E ratio 2016 |
-3.53
x | P/E ratio 2017 |
-33.2
x | Employees | 6 |
| Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 70.57% |
More Fundamentals
* Assessed data
| 1 day | -66.67% | ||
| Current month | -66.67% | ||
| 1 month | -66.67% | ||
| 3 months | -66.67% | ||
| 6 months | -66.67% | ||
| Current year | -66.67% |
1 month
0.00
0.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.17
5 years
0.000.50
10 years
0.004.58
Curative Biosciences, Inc., formerly Amaize Beverage Corporation, is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD (hemp derived Cannabidiol). The Companyâs product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The Company through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -66.67% | 129K | |
| -0.18% | 2.97B | |
| +70.51% | 1.59B | |
| +106.35% | 68.82M |
- Stock Market
- Equities
- CBDX Stock
